ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,595.76
      0.75%
      US Tech 100
      18,933.41
      1.01%
      Dow Jones
      41,096.77
      0.58%
      Brent Oil
      72.025
      0.08%
      Bitcoin
      57,897.98
      -0.41%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Supergen, Inc. (MM) (SUPG) Quote

      Supergen, Inc. (MM)

      Supergen, Inc. (MM) (SUPG)

      NASDAQ
      2.03
      0.00
      (0.00%)
      Closed September 13 4:00PM
      Delayed by 15 minutes
      0.00
      0.00
      (0.00%)
      After Hours: -
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      2.03
      Bid
      0.00
      Ask
      0.00
      Volume
      -
      0.00 Day's Range 0.00
      0.00 52 Week Range 0.00
      Previous Close
      2.03
      Open
      -
      Last Trade
      Last Trade Time
      Average Volume (3m)
      -
      Financial Volume
      -
      VWAP
      -

      Ask ADVFN Intelligence (AI)

      SUPG Latest News

      More News

      SuperGen to Present at Rodman & Renshaw Annual Healthcare Conference as Astex Pharmaceuticals, Inc. on September 12th

      SuperGen, Inc. (NASDAQ:SUPG), a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, today announced that James S.J. Manuso, Ph.D...

      September 02 2011
      Business Wire

      SuperGen Reports 2011 Second Quarter Financial Results

      SuperGen, Inc. (NASDAQ: SUPG) today reported financial results for the second quarter ended June 30, 2011. The Company reported net income for the 2011 second quarter of...

      August 03 2011
      Business Wire

      SuperGen to Announce 2011 Second Quarter Financial Results on August 3, 2011

      SuperGen, Inc. (Nasdaq:SUPG), a pharmaceutical company dedicated to discovery and development of novel cancer therapies, announced that it will release its 2011 second quarter...

      July 22 2011
      Business Wire

      SuperGen Completes Acquisition of Astex Therapeutics

      SuperGen, Inc. (NASDAQ:SUPG), a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, announced it has closed the transaction to acquire...

      July 20 2011
      Business Wire

      FDA Accepts DACOGEN® (Decitabine) sNDA Submission in Acute Myeloid Leukemia

      SuperGen, Inc. (NASDAQ:SUPG), a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, announced that Eisai Inc. today released information...

      July 13 2011
      Business Wire

      SuperGen President & CEO Elected to BIO Board of Directors

      SuperGen, Inc. (NASDAQ:SUPG), a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, announced that its chairman, president and chief...

      June 28 2011
      Business Wire

      SuperGen Stockholders Approve Stock Issuance In Connection with the Proposed Acquisition of Astex Therapeutics Limited

      SuperGen, Inc. (NASDAQ:SUPG), a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, announced that stockholders have approved the...

      June 16 2011
      Business Wire

      SuperGen, Inc. Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com

      SuperGen, Inc. Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com Company invites individual and institutional investors to log-on to view its President and CEO...

      June 06 2011
      PR Newswire (US)

      Eisai & Janssen Announce the Presentation of DACOGEN® (decitabine) Data at ASCO from a Phase III Study in Patients with Acut...

      Eisai Inc. and Janssen, a Johnson & Johnson Company, both announced the presentation of data from the DACO-016 trial of DACOGEN® (decitabine) at the 2011 Annual Meeting of the...

      June 06 2011
      Business Wire
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10000000CS
      40000000CS
      120000000CS
      260000000CS
      520000000CS
      1560000000CS
      2600000000CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      GVVisionary Holdings Inc
      $ 4.41
      (117.24%)
      		45.83M
      EGIOEdgio Inc
      $ 2.11
      (115.64%)
      		106.78M
      OBLGOblong Inc
      $ 6.42
      (89.38%)
      		33.47M
      MNPRMonopar Therapeutics Inc
      $ 3.9123
      (63.01%)
      		35.61M
      TILInstill Bio Inc
      $ 46.48
      (56.76%)
      		1.86M
      FULCFulcrum Therapeutics Inc
      $ 3.45
      (-61.02%)
      		33.14M
      ONCTOncternal Therapeutics Inc
      $ 1.69
      (-59.33%)
      		630.54k
      MODVModivCare Inc
      $ 12.75
      (-59.12%)
      		3.57M
      CNEYCN Energy Group Inc
      $ 0.6899
      (-50.37%)
      		16.05M
      UPCUniverse Pharmaceuticals Inc
      $ 1.51
      (-50.33%)
      		19.77M
      NVDANVIDIA Corporation
      $ 119.14
      (1.91%)
      		367.08M
      SQQQProShares UltraPro Short QQQ
      $ 8.28
      (-2.93%)
      		181.17M
      PEGYPineapple Energy Inc
      $ 0.1846
      (5.97%)
      		114.66M
      EGIOEdgio Inc
      $ 2.11
      (115.64%)
      		106.98M
      SMFLSmart for Life Inc
      $ 1.20
      (41.18%)
      		89.61M

      Discussion

      View Full Feed
      ramfan60 ramfan60 4 minutes ago
      Well Kiwi, be skeptical when studies are referenced...... who benefits by a favorable study on a Trillion dollar drug? Who sponsored said studies? Follow the money!

      Let me know what you think of this presentation.

      https://www.youtube.com/watch?v=I7r4j1u42V8
      AMRN
      nwtf nwtf 4 minutes ago
      Shorts dont have to cover because there isnt any. This issue has been sub zero for well over 6 years now. So shorts covered a long time ago. Anyone whose been in the market for any length of time knows this to be true. There is no reason for a short seller to hold a position in a worthless issue.
      ERHE
      Disquisition Disquisition 4 minutes ago
      CLASS ACTION DUMPING
      OM
      JMCK6193 JMCK6193 4 minutes ago
      Lol you too turbo.
      RXMD
      fuagf fuagf 4 minutes ago
      Ok, and when your appreciating Loomer has MTG looking negatively at you you have real in-cult problems. To end ..

      And last year, the New York Times reported that Trump had expressed an interest in hiring her for his campaign, relenting only after top aides expressed concern that she
      ZLAZARUS ZLAZARUS 6 minutes ago
      Looking good here. We shoud see 7.00 in no time
      VLRS
      konshe konshe 6 minutes ago
      See Tomorrow trading at 3/4. TKMO is ready to run with some news out
      TKMO
      Disquisition Disquisition 6 minutes ago
      UNFATHOMABLE DUMPING
      AEHL
      Acme Investments Acme Investments 6 minutes ago
      Check the disclosure on otc markets!!
      JAMN
      JusDePomme JusDePomme 7 minutes ago
      Hey Tommyboy is one of ihub expert trader ! Be nice to him man
      GTVH
      Acme Investments Acme Investments 7 minutes ago
      Uh,oh machine!! Looks like the merger is still on!! Check the Disclosure!! Lol!!
      JAMN
      stockinspector stockinspector 7 minutes ago
      I am!
      WDLF
      Oleblue Oleblue 9 minutes ago
      IBM near all time new high.

      https://api.wsj.net/api/kaavio/charts/big.chart?nosettings=1&symb=ibm&uf=32&type=4&size=4&sid=2595&style=330&freq=2&entitlementtoken=0c33378313484ba9b46b8e24ded87dd6&time=20&rand=198751218&compidx=aaaaa%3a0&ma=2&maval=8&lf=1&lf2=4&lf3=8&height=981&width=104
      IBM
      Vexari Vexari 11 minutes ago
      Knew someone that gave half their liver

      Totally replaced with the half of another

      Over time

      Both came through with complete organs

      Strong stuff
      KoenigSalomon KoenigSalomon 11 minutes ago
      as soon as the new PRPM CEO is posting on ihub its confirmed he is a scammer.
      So hopefully we never met him on ihub.

      Give him a call and discuss directly.
      PRPM
      4retire 4retire 11 minutes ago
      Sorry to see you go. Enjoyed and learned from your posts. GLTY
      NVDA
      ZLAZARUS ZLAZARUS 12 minutes ago
      I believe the 50 million in near-term upfront license fees and milestone payments is already priced into the stock. I believe the real movement will come when Pfizer speaks about the Phase 3 dataset from the AFFINE trial in the up and coming months. Not to mention, we will probably see a press relea
      SGMO
      bas2020 bas2020 16 minutes ago
      JT hates being schooled by knowledgeable posters. He goes into defensive attack mode... so immature... so lame.
      NWBO
      janice shell janice shell 16 minutes ago
      That sounds complicated.
      janice shell janice shell 17 minutes ago
      I certainly hope so. We cannot afford to be governed by Trumpist fools.
      janice shell janice shell 18 minutes ago
      What are "Maccas"??
      Acme Investments Acme Investments 18 minutes ago
      Loaded Up!! Strong 💪!! Waiting for the shop to open!! For those who still fail to think!! Jake now owns an Asset!! That means it can be sold!! Dumping shares would be very foolish!!
      BCAP

      Your Recent History

      NASDAQ
      SUPG
      BOV
      BABA34R
      Alibaba
      Delayed Upgrade Clock